Topic Review - Newest First (only newest 5 are displayed)

ConciseGem

Hepatitis C

Hepatitis C Among Men Of Ages Between 30-40

The purpose of this study is to show the rates of Hepatitis C infection among men aged 30 to 40. Hepatitis C infection takes place among men of all ages, but the highest rates are to be found among individuals who are 20 to 39.

In the entire world, Hepatitis C virus (HCV) is a prominent cause of infections, including chronic liver, hepatocellular carcinoma, and cirrhosis, which is the most dominant symptom for the transplantation of liver. Even though the incidence of hepatitis C virus has considerably decreased throughout the previous decade, the universal pool of constantly infected people is estimated around 170 million, or a total of 3 percent of the population of the entire world. The rate of continual Hepatitis C infection is influenced by a person's age, sex, race, and viral resistant response. About 75 to 85 percent of Hepatitis C victims will progress to chronic HCV disease, and are at jeopardy for the expansion of extra hepatic symptoms, rewarded as well as unrewarded cirrhosis, as well as hepatocellular carcinoma (HCC). An anticipated 10-15 percent of Hepatitis C infected people will move forward to cirrhosis in the first 20 years. Persons who have cirrhosis are at greater risk of contracting HCC. A perspective of hepatitis C infection is really necessary to efficiently control, take care of, and advocate for persons who have HCV illness.

Comparison of Hepatitis C Virus Between Men and Women

To estimate the prevalence and predictors of hepatitis C virus (HCV) infection among men and women, the reaction of antibodies to HCV varied but is more prominent in men than women. Contrasted with homosexuals, Intravenous male drug addicts of those ages had the maximum danger of carrying the antibodies to the hepatitis C virus.

A person who has constant HCV will develop HCC 1 to 5 % of the time after twenty years, with salient differences in rates in all over the world. Once cirrhosis is recognized, the growth-pace of HCC raises to 1 to 4% yearly. And, in comparison, among patients with cirrhosis, hepatitis C expands more frequently in men than in women.

Factors of Hepatitis C among Men of ages between 30-40

The occurrence of this disease was lowest in people who are 6-29 years-old (0.4 percent) and highest in people who are 30-40 years-old ( Almost 7.1 percent among men). The occurrence of this infection varied among a number of demographic factors:

Persons who had ever injected drugs or other intoxicants had a far greater chance of occurrence of this perilous disease (57.3 percent) than those who had second-hand non-injected drugs (3.5 percent) or persons who had by no means used any kind of drugs (0.7 percent).

Hazardous factors connected with the spread of Hepatitis C worldwide consist of blood transplantation, injection of drugs, working in a patient or medical laboratory, sexual intercourse with someone who has had this disease in the past, or with someone who has had partners who are at risk for this disease, and low socioeconomic level.

Hypothesis

One hypothesis is that many of the hepatitis C patients may have injecting sexual partners. Risk goes up with the number of lifetime sexual partners. People with 0-1 partners contract the disease 0.5% of the time; people with 2-9 partners, 1% of the time; 10-49 partners, 4.7%; 50 or more partners, 12.1% of the time.

To avoid chronic Hepatitis C infection, people should avoid high-risk behavior. To accomplish this goal, the health authority needs to prevent high-risk behavior and observe infection trends. Key high-risk behaviors include sexual transmission of HCV and the illegal use of injected drugs in men ages 30-40.

The periods for Hepatitis C incubation among people of ages 30 to 40 are normally 2-26 weeks. Symptoms can be observed in as little as 2 weeks, although the generation of antibodies can take 8-9 weeks. This long gap can give significant opportunity to observe the disease. About 20-30% of those who are initially suspected of having HCV will turn out to have jaundice. Conclusion

By and large occurrence of HCV disease has not changed throughout the previous 10 years The age at which people contract the disease has risen, however, into the 30s. The main culprit is the high-risk behaviors that make the disease spread rapidly.

References

Theo, Smart. (19th January, 2006). Co-management of HIV and Hepatitis B or C. Retrieved September 23, 2006, Web site: http://www.aidsmap.com/cms1037665.asp

Newcomb-Fernandez, Jennifer. (Fall, 2004). “An Overview of Hepatitis C and HIV”. Research Initiative Treatment action, Retrieved September 24, 2006, Web site: http://www.findarticles.com/p/articles/mi_m0EXV/is_2_10/ai_n13650940

Hepatitis Foundation International. “The basics of Hepatitis C”. Retrieved September 23, 2006, Web site: http://www.hepfi.org/living/liv_abc.html

Chen SL, & Morgan TR. (2006). “The History of Hepatitis C infection – natural History”. Int J Med Sci, 3:47-52. Retrieved from Web site: http://www.medsci.org/v03p0047.htm

Raymond, Daniel. (May, 2006). “Hepatitis C among African Americans: history on Schering controversy”. Retrieved September 23, 2006, from Web site: http://hepcproject.typepad.com/hep_c_project/2006/05/african_america.html

Weekly Report on Morbidity and Mortality. (2001, June 29). “U.S. PHS Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Post-exposure Prophylaxis. Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease”. MMWR 50 (No. RR-11). Retrieved September 23, 2006, from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5011a1.htm.

Morbidity and Mortality Weekly Report. (199. “The recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease”. MMWR 47 (No. RR-19). Retrieved September 3, 2006, from http://www.cdc.gov/mmwr/preview/mmwrhtml/00055154.htm.

Mingdong Zhang, & Xiu-Di Sun, & Steven D. Mark, & Wen Chen, & Lara Wong, & Sanford M. Dawsey, & You-Lin Qiao, & Joseph F. Fraumeni, Jr., & Philip R. Taylor, & Thomas R. O’Brien. (January, 2005). “HCV Infection. Emerging Infectious diseases”. Retrieved September 24, 2006, from Web site: http://www.findarticles.com/p/articles/mi_m0GVK/is_1_11/ai_n8966496

R.A. Coutinho. (August 15, 199. “HVC Infection Among Inoculating drug users”. Retrieved September 24, 2006, from Web site: http://www.findarticles.com/p/articles/mi_m0999/is_n7156_v317/ai_21139046

Swan, Tracy. (Fall, 2004). “Present challenges of HVC”. Research Initiative and Treatment Action. Retrieved September 24, 2006, from Web site: http://www.findarticles.com/p/articles/mi_m0EXV/is_2_10/ai_n13650941